BioTrinity is a two day life sciences conference that in response to the new coronavirus outbreak will be delivered digitally.
BioTrinity focuses on partnering, investment and collaboration and aims to inspire growth and create opportunities for all who attend.
The core delegate mix includes early-stage and emerging biotech, medtech and digital health companies, big pharma executives and life sciences investors. Examples of panel discussions are what’s new in cell and gene therapy and gene editing, what’s new in antimicrobial resistance, an update on Brexit and the life science industry, where now for neurodegenerative research, what’s new in medical diagnostics, and much more.
Read more about BioTrinity 2020 here!